devxlogo

Neuralink raises $650 million as clinical trials begin

Neuralink raises $650 million as clinical trials begin
Neuralink raises $650 million as clinical trials begin

Elon Musk’s brain-chip company, Neuralink, has raised $650 million in its latest funding round. This financial boost comes as the company begins clinical trials, a key step in developing advanced neural interfaces. President Donald Trump and Elon Musk announced the funding at a White House news conference on May 30, 2025.

https://x.com/neuralink/status/1929604804411904096

The investment shows growing confidence in Neuralink’s technology, which aims to enhance human brain capabilities through cutting-edge computer interfaces.

https://x.com/SawyerMerritt/status/1929606391246762060

The funds will help expand research and development, scale up manufacturing, and speed up the use of Neuralink’s technology in clinical settings. The main focus will be on developing solutions for patients with severe neurological conditions like paralysis and brain injuries.

https://x.com/SawyerMerritt/status/1929605170507259977

Neuralink’s clinical trial boost

“Neuralink’s latest achievement is a testament to the groundbreaking work our team is doing,” said Musk. “These funds will help speed up our efforts to bring our technology to those who need it most.”

The funding also highlights the enthusiasm and support from investors for technologies that push the boundaries of human-machine integration.

https://x.com/teslaownersSV/status/1929672143035683095

Investors are optimistic about the potential societal and medical impacts of Neuralink’s brain-computer interface. Neuralink has been progressing rapidly since it started. It has already shown several prototypes that have demonstrated the potential to restore movement in paralyzed patients and even improve cognitive abilities.

As clinical trials move forward, the world will be watching to see if Neuralink can deliver on its ambitious promises and revolutionize the future of neurotechnology.

About Our Editorial Process

At DevX, we’re dedicated to tech entrepreneurship. Our team closely follows industry shifts, new products, AI breakthroughs, technology trends, and funding announcements. Articles undergo thorough editing to ensure accuracy and clarity, reflecting DevX’s style and supporting entrepreneurs in the tech sphere.

See our full editorial policy.